Patent · US Active

Prodrugs of urolithins and uses thereof

US11180468B2 · kind B2 · utility

4Cited by

5References

24Claims

0Family size

Assignee

Amazentis SA · CH

Inventors

Christopher L. Rinsch · Morges, CH
Rune Ringom

Key dates

Filing date	Jan 13, 2020
Grant date	Nov 23, 2021
Priority date	—
Expiry date	Jan 13, 2040

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D405/12
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The invention provides compounds of formula (I) or salts thereof: The compounds are effective pro-drugs for urolithins and they enable the ready delivery of urolithins to the site in the digestive tract where they can be absorbed into the body.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.